News | March 09, 2023
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
Implants from the U.S. startup Allay Therapeutics are designed to relieve pain after knee surgery for up to three weeks
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
NFIL’s ambition is to reach revenues of US$100mn from CDMO by FY25.
Availability of pharmaceutical-grade materials with broad API compatibility key to advancing drug delivery solutions
New material distribution will serve medical device and pharmaceutical packaging manufacturers.
The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes.
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Subscribe To Our Newsletter & Stay Updated
